These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10908121)

  • 21. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymicrobial endocarditis caused by methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococci.
    Bishara J; Sagie A; Samra Z; Pitlik S
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):674-5. PubMed ID: 10534195
    [No Abstract]   [Full Text] [Related]  

  • 23. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on anti-MRSA parenteral cephalosporins. I. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- hydroxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1053-70. PubMed ID: 11132950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
    D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
    Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Cephem-induced vancomycin resistance" observed in phenotypically methicillin-sensitive Staphylococcus aureus isolated from a patient treated with vancomycin and cephems.
    Iwakawa K; Kizu J; Hosaka Y; Yamamoto K
    Jpn J Infect Dis; 2000 Aug; 53(4):167-9. PubMed ID: 11056561
    [No Abstract]   [Full Text] [Related]  

  • 29. [Conjugative transfer of glycopeptide and macrolide resistant genes among Enterococci and from Enterococcus faecalis to Staphylococcus aureus].
    Młynarczyk A; Młynarczyk G; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):21-8. PubMed ID: 12185680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus.
    Weigel LM; Clewell DB; Gill SR; Clark NC; McDougal LK; Flannagan SE; Kolonay JF; Shetty J; Killgore GE; Tenover FC
    Science; 2003 Nov; 302(5650):1569-71. PubMed ID: 14645850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Kamiyama K; Matsunaga N; Tawada H; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1071-85. PubMed ID: 11132951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
    Berges DA
    J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl cephalosporins including SCE-2787.
    Miyake A; Yoshimura Y; Yamaoka M; Nishimura T; Hashimoto N; Imada A
    J Antibiot (Tokyo); 1992 May; 45(5):709-20. PubMed ID: 1624373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.
    Huang V; Brown WJ; Rybak MJ
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2719-23. PubMed ID: 15215134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.
    Ternansky RJ; Draheim SE; Pike AJ; Bell FW; West SJ; Jordan CL; Wu CY; Preston DA; Albron W; Kasher JS
    J Med Chem; 1993 Jul; 36(14):1971-6. PubMed ID: 8336336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on 3'-quaternary ammonium cephalosporins--III. Synthesis and antibacterial activity of 3'-(3-aminopyrazolium) cephalosporins.
    Ohki H; Kawabata K; Inamoto Y; Okuda S; Kamimura T; Sakane K
    Bioorg Med Chem; 1997 Mar; 5(3):557-67. PubMed ID: 9113334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF
    Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
    Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin.
    Hoellman DB; Pankuch GA; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4037-9. PubMed ID: 15388474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.